Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effectiveness of an Early Nutrition Program on Promoting Breastfeeding and Optimizing Infant Growth and Diet Quality

3 aprile 2018 aggiornato da: Prof. Man-sau WONG, The Hong Kong Polytechnic University

Effectiveness of a Community Based Early Nutrition Program on Promoting Breastfeeding and Optimizing Infant Growth and Diet Quality

Effective early life programs that reduce the long-term non-communicable diseases (NCDs) risk could bring great economic benefits to the society. However, there is a lack of local data on the effect of nutrition on child growth and most research on early life intervention focus on disease models such as obese women to improve offspring health outcomes. There is limited research on postpartum interventions in the community that optimize maternal and infant nutrition through improving success of breastfeeding, infant growth diet quality and microbiota to enhance health in the adulthood.

In this study, it is hypothesized that our early nutrition program could promote breastfeeding successful rate (increase the number of months the mothers breastfed their infants) and improve growth status, diet quality and microbiota of the infants which may reduce the risk of NCDs in the adulthood. The planned project proposal would like to include 240 pairs of mothers and infants. In order to test the protocol in the planned proposal, the investigators hope to run a pilot study to set up this community based early nutrition program including breastfeeding workshops and supports, healthy lifestyle courses, parenting education, introduction of solid foods for infants, child development and cooking classes of infant foods. the investigators will evaluate the effectiveness of this early nutrition program and determine its impacts on breastfeeding, infant growth (by comparing infants' biomarkers and microbiota in different stages) , diet quality and microbiota, as well as the benefits to the postpartum mothers such as reducing the postpartum weight retention so that to generate pilot result and facilitate the up scale study that the investigators proposed in the planned proposal.

The ultimate goal is that a long term follow up with the children in this project could also be arranged to determine the long term health effects of this early nutrition program.

Panoramica dello studio

Stato

Sconosciuto

Intervento / Trattamento

Descrizione dettagliata

Study background:

Effective early life programs that reduce the long-term non-communicable diseases (NCDs) risk could bring great economic benefits to the society. NCDs are responsible for roughly two-thirds of worldwide death and cause large burden of health care cost. Most policies nowadays that combat disease focus on treatment after disease occurs and on reducing risk factors in adult life. Early life interventions are an unexplored and promising new avenue of health policy . One of the oldest US early life intervention programs, the Carolina Abecedarian Project, started from 1970s has been shown to have substantial benefits in boosting adult health. However, most research on early life intervention focus on disease models such as obese women to improve offspring health outcomes. There is limited research on postpartum interventions in the community that optimize maternal and infant nutrition through improving success of breastfeeding, infant growth, diet quality and microbiota to enhance health in the adulthood

Aim of study:

To evaluate the effects of postpartum nutrition program on i) success of breastfeeding by comparing the average duration of breastfeeding between intervention group and control group (primary outcome) ii) diet quality of the infants and mothers (secondary outcome) The diet quality will be measured by 3-day dietary records using Diet Quality Index-International (DQI-I).

Briefly, the DQI-I assesses four categories (variety, adequacy, moderation, and overall balance) and contains six food items and 11 nutrient items. This scoring scale is complex. The maximum possible score for each category ranges from 10 to 40 points, and the full score is 100 points.

Paired t-tests will be used to compare the difference between intervention group and control group.

iii) the infant growth by comparing the Z-scores of weight-for-age, length-for-age, BMI-for-age and head circumference-for-age at 2, 4, 6, 8, 10 and 12 month old between intervention group and control group (secondary outcome) Z-score (or SD-score) = (observed value - median value of the reference population) / standard deviation value of reference population

iv) the microbiota profiles (secondary outcome)

Method of Investigation:

In this project, a randomized controlled trial will be conducted which subjects will be 40 pairs of local Chinese healthy postpartum mothers aged 18-40 years old and their infants. The participants will be randomly assigned into 1:1 ratio to the control group or the intervention group. A study coordinator will randomize subjects by means of a computer-generated list of random numbers in blocks of 4. Treatment assignments will be concealed in consecutively-numbered sealed envelopes, which will be opened sequentially upon subject enrollment.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

96

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Non più vecchio di 40 anni (Bambino, Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria for mothers:

  • Postpartum mothers: Aged 18-40 years old
  • Hong Kong residents having resided in Hong Kong for a continuous period of not less than 18 months
  • vaginal delivery at full term (>37 gestation weeks)
  • first pregnancy and give birth to singleton infant

Inclusion Criteria for Infants:

  • Full term
  • Born by vaginal delivery (>37 gestation weeks)
  • singleton infant with no known abnormality.

Exclusion Criteria:

  • Concurrent participation in any clinical trial or study
  • Complicated pregnancy such as preeclampsia and gestational diabetes
  • Special dietary restrictions for examples gluten-free diets, vegan or any restrictions due to food allergies;
  • Suffer from renal, liver or thyroid dysfunction, cognitive impairment, or any other indication of a major medical or psychological illness, as judged by the investigators as ineligible to participate the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Control

Control group will receive standard health care.

To improve the compliance of the subjects, both intervention group and control group can attend one vision development workshop at 2-month postpartum and two parenting workshops at 6- and 12-month postpartum.

Sperimentale: Nutrition education program

The intervention group will receive an early nutrition program for 12 months. Workshops format will be mainly in form of talks and experience sharing groups which run by lactation consultants, nutritionists / dietitians. All classes and workshops will be run for 4-6 times to cater for subjects recruited in different phases.

To improve the compliance of the subjects, both intervention group and control group can attend one vision development workshop at 2-month postpartum and two parenting workshops at 6- and 12-month postpartum.

online platform support, workshop, seminar and cooking demo etc

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Success rate of breastfeeding
Lasso di tempo: through study completion, an average of 1 year
success rate of breastfeeding by comparing the average duration of breastfeeding
through study completion, an average of 1 year

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Diet quality
Lasso di tempo: through study completion, an average of 1 year
Diet quality of the infants and mothers at 2, 4, 6, 8, 10 and 12 month old
through study completion, an average of 1 year
Infant growth
Lasso di tempo: through study completion, an average of 1 year
Infant growth by comparing the Z-scores of weight-for-age, length-for-age, BMI-for-age and head circumference-for-age at 2, 4, 6, 8, 10 and 12 month old
through study completion, an average of 1 year
Microbiota profiles
Lasso di tempo: through study completion, an average of 1 year
Microbiota profiles at 2, 4, 6, 8, 10 and 12 month old
through study completion, an average of 1 year

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Man-sau Wong, PhD, The Hong Kong Polytechnic University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Anticipato)

16 aprile 2018

Completamento primario (Anticipato)

30 settembre 2019

Completamento dello studio (Anticipato)

30 settembre 2019

Date di iscrizione allo studio

Primo inviato

20 marzo 2018

Primo inviato che soddisfa i criteri di controllo qualità

3 aprile 2018

Primo Inserito (Effettivo)

10 aprile 2018

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 aprile 2018

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 aprile 2018

Ultimo verificato

1 aprile 2018

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • CUHKFSTRC2018-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi